RE:RE:Under the radar progress. It is not unusual for various pharma partners to hold back for the time being and for there to be no information - the market for cannabis has not been regulated for years and the whole thing has only got rolling in the last few months. For example, the legal changes in Germany or the fact that the DEA has approved the FDA's two-stage evaluation for cannabis medicines - as long as it is not clear whether there is a market for it, the pharmaceutical industry will hold back. But now a lot has happened and a clear picture of a pharmaceutical market for cannabinoids is emerging